cp wire

CP Wire Articles

BeiGene Proposes $800+ Million Offering


 BeiGene, Ltd. (NASDAQ:BGNE) announced on 7/27/18 a Hong Kong initial public offering and a global offering (the “Offering”) of 65,600,000 of its ordinary shares and the proposed listing of... read more

Fri, 07/27/18 - 10:37 am
Alnylam Receives Positive CHMP Opinion for Hereditary Amyloidosis Treatment
  • European Medicines Agency reviewed patisiran under the accelerated assessment procedure
  • Patisiran is currently under priority review as a Breakthrough Therapy with the US FDA
    • ... read more
Fri, 07/27/18 - 10:01 am
Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma



Merck (NYSE:MRK) announced on 7/26/18 that Keytruda, Merck’s anti-PD-1 therapy, has been approved by the China National Drug Administration (CNDA) for the treatment of adult patients with... read more

Thu, 07/26/18 - 09:47 am
Omeros Prevails in Patent Dispute With Sandoz
  • Sandoz's ANDA cannot be approved until after all patents expire in 2033
  • Omeros previously settled lawsuits against Par and Lupin


Omeros Corporation (Nasdaq: OMER)... read more

Thu, 07/26/18 - 09:12 am
BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China
  • Tislelizumab is a monoclonal antibody PD-1 checkpoint inhibitor
  • BeiGene and Celgene have a global collaboration agreement for the development of  tislelizumab outside of Asia (except... read more
Wed, 07/25/18 - 09:49 am

Pages